T1	Age 34 38	aged
E1	Age:T1
T2	Eq-Comparison 39 50	6-36 months
E2	Eq-Comparison:T2 Value:T80 Operator:T81 Value:T82 Temporal-Unit:T83
T3	Condition 69 86	Atopic Dermatitis
E3	Condition:T3 Name:T84
T4	Observation 100 112	SCORAD index
E4	Observation:T4
T5	Age 137 140	Age
E5	Age:T5
T6	Eq-Comparison 141 151	< 6 months
E6	Eq-Comparison:T6 Operator:T85 Value:T86 Temporal-Unit:T87
T7	Age 157 160	age
E7	Age:T7
T8	Eq-Comparison 161 172	> 36 months
E8	Eq-Comparison:T8 Operator:T88 Value:T89 Temporal-Unit:T90
T9	Modifier 179 183	skin
E9	Modifier:T9
T10	Condition 184 194	infections
E10	Condition:T10
T11	Condition 201 211	ichthyosis
E11	Condition:T11 Name:T92
T12	Allergy 223 232	allergies
E12	Allergy:T12
T13	Other 239 244	other
E13	Other:T13
T14	Condition 245 262	allergic diseases
E14	Condition:T14 Name:T93
T15	Modifier 269 285	chronic systemic
E15	Modifier:T15
T16	Condition 286 294	diseases
E16	Condition:T16
T17	Condition 301 327	congenital cardiac defects
E17	Condition:T17 Name:T95
T18	Eq-Comparison 334 340	active
E18	Eq-Comparison:T18 Temporal-Period:T96
T19	Condition 341 353	tuberculosis
E19	Condition:T19 Name:T97
T20	Condition 360 379	autoimmune diseases
E20	Condition:T20 Name:T98
T21	Condition 386 402	immunodeficiency
E21	Condition:T21 Name:T99
T22	Modifier 409 416	chronic
E22	Modifier:T22
T23	Condition 417 444	inflammatory bowel diseases
E23	Condition:T23 Name:T100
T24	Condition 451 465	celiac disease
E24	Condition:T24 Name:T101
T25	Condition 472 487	cystic fibrosis
E25	Condition:T25 Name:T102
T26	Condition 494 512	metabolic diseases
E26	Condition:T26 Name:T103
T27	Condition 519 529	malignancy
E27	Condition:T27 Name:T104
T28	Modifier 536 543	chronic
E28	Modifier:T28
T29	Condition 544 562	pulmonary diseases
E29	Condition:T29 Name:T105
T30	Condition 569 582	malformations
E30	Condition:T30 Name:T106
T31	Modifier 590 606	gastrointestinal
E31	Modifier:T31
T32	Or 607 613	and/or
E32	Or:T32
T33	Condition 614 631	respiratory tract
E33	Condition:T33 Name:T107
T34	Procedure 656 678	prebiotics/ probiotics
E34	Procedure:T34
T35	Or 678 679	/
E35	Or:T35
T36	Modifier 679 688	symbiotic
E36	Modifier:T36
T37	Or 688 689	/
E37	Or:T37
T38	Modifier 689 697	systemic
E38	Modifier:T38
T39	Condition 698 714	immunomodulators
E39	Condition:T39 Name:T109
T40	Temporal-Connection 715 721	during
E40	Temporal-Connection:T40
A1	Temporal-Connection-Type-Value E40 during
T41	Eq-Comparison 726 733	4 weeks
E41	Eq-Comparison:T41 Value:T110 Temporal-Unit:T111
T42	Temporal-Connection 734 740	before
E42	Temporal-Connection:T42
A2	Temporal-Connection-Type-Value E42 before
T43	Study 741 750	enrolment
E43	Study:T43
T44	Procedure 757 767	treatments
E44	Procedure:T44
T45	Drug 773 797	topical immunomodulators
E45	Drug:T45 Name:T112
T46	Drug 799 809	Tacrolimus
E46	Drug:T46 Name:T113
T47	Or 810 812	or
E47	Or:T47
T48	Drug 813 825	Pimecrolimus
E48	Drug:T48 Name:T114
T49	Eq-Comparison 827 848	over the three months
E49	Eq-Comparison:T49 Value:T115 Temporal-Unit:T116
T50	Temporal-Connection 849 857	prior to
E50	Temporal-Connection:T50
A3	Temporal-Connection-Type-Value E50 before
T51	Study 858 867	enrolment
E51	Study:T51
T52	Drug 881 896	corticosteroids
E52	Drug:T52 Name:T118
T53	Or 897 899	or
E53	Or:T53
T54	Drug 900 911	calcineurin
E54	Drug:T54
T55	Drug 912 923	antagonists
E55	Drug:T55
T56	Or 924 926	or
E56	Or:T56
T57	Drug 927 939	phototherapy
E57	Drug:T57 Name:T120
T58	Eq-Comparison 947 963	previous 4 weeks
E58	Eq-Comparison:T58 Temporal-Period:T121 Value:T122 Temporal-Unit:T123
T59	Drug 977 997	systemic antibiotics
E59	Drug:T59 Name:T125
T60	Or 998 1000	or
E60	Or:T60
T61	Drug 1001 1019	anti-mycotic drugs
E61	Drug:T61 Name:T126
T62	Temporal-Connection 1020 1026	during
E62	Temporal-Connection:T62
A4	Temporal-Connection-Type-Value E62 during
T63	Eq-Comparison 1027 1034	4 weeks
E63	Eq-Comparison:T63 Value:T127 Temporal-Unit:T128
T64	Temporal-Connection 1035 1041	before
E64	Temporal-Connection:T64
A5	Temporal-Connection-Type-Value E64 before
T65	Study 1042 1047	study
E65	Study:T65
T66	Other 1203 1208	other
E66	Other:T66
T67	Study 1209 1216	studies
E67	Study:T67
T68	Study 1227 1242	investigational
E68	Study:T68
T69	Or 1243 1245	or
E69	Or:T69
T70	Drug 1246 1263	marketed products
E70	Drug:T70
T71	Or 1278 1280	or
E71	Or:T71
T72	Eq-Comparison 1281 1297	within two weeks
E72	Eq-Comparison:T72 Operator:T129 Value:T130 Temporal-Unit:T131
T73	Temporal-Connection 1298 1306	prior to
E73	Temporal-Connection:T73
A6	Temporal-Connection-Type-Value E73 before
T74	Study 1307 1312	entry
E74	Study:T74
T75	Study 1322 1327	study
E75	Study:T75
T76	Condition 1334 1350	hypersensitivity
E76	Condition:T76 Name:T132
T77	Study 1378 1383	study
E77	Study:T77
T78	Drug 1384 1391	product
E78	Drug:T78
T79	Life-Stage-And-Gender 25 33	Children
A7	Life-Stage-And-Gender-Type T79 child
T80	Eq-Value 39 40	6
T81	Eq-Operator 40 41	-
A8	Eq-Operator-Value T81 BETWEEN
T82	Eq-Value 41 43	36
T83	Eq-Temporal-Unit 44 50	months
A9	Eq-Temporal-Unit-Value T83 month
T84	Condition-Name 69 86	Atopic Dermatitis
T85	Eq-Operator 141 142	<
A10	Eq-Operator-Value T85 LT
T86	Eq-Value 143 144	6
T87	Eq-Temporal-Unit 145 151	months
A11	Eq-Temporal-Unit-Value T87 month
T88	Eq-Operator 161 162	>
A12	Eq-Operator-Value T88 GT
T89	Eq-Value 163 165	36
T90	Eq-Temporal-Unit 166 172	months
A13	Eq-Temporal-Unit-Value T90 month
T91	Condition-Name 179 194	skin infections
T92	Condition-Name 201 211	ichthyosis
T93	Condition-Name 245 262	allergic diseases
T94	Condition-Name 277 294	systemic diseases
T95	Condition-Name 301 327	congenital cardiac defects
T96	Eq-Temporal-Period 334 340	active
A14	Eq-Temporal-Period-Value T96 present
T97	Condition-Name 341 353	tuberculosis
T98	Condition-Name 360 379	autoimmune diseases
T99	Condition-Name 386 402	immunodeficiency
T100	Condition-Name 417 444	inflammatory bowel diseases
T101	Condition-Name 451 465	celiac disease
T102	Condition-Name 472 487	cystic fibrosis
T103	Condition-Name 494 512	metabolic diseases
T104	Condition-Name 519 529	malignancy
T105	Condition-Name 544 562	pulmonary diseases
T106	Condition-Name 569 582	malformations
T107	Condition-Name 614 631	respiratory tract
T108	Drug-Name 656 678	prebiotics/ probiotics
T109	Condition-Name 698 714	immunomodulators
T110	Eq-Value 726 727	4
T111	Eq-Temporal-Unit 728 733	weeks
A15	Eq-Temporal-Unit-Value T111 week
T112	Drug-Name 773 797	topical immunomodulators
T113	Drug-Name 799 809	Tacrolimus
T114	Drug-Name 813 825	Pimecrolimus
T115	Eq-Value 836 841	three
T116	Eq-Temporal-Unit 842 848	months
A16	Eq-Temporal-Unit-Value T116 month
T117	Eq-Temporal-Period 874 877	use
A17	Eq-Temporal-Period-Value T117 present
T118	Drug-Name 881 896	corticosteroids
T119	Drug-Name 900 923	calcineurin antagonists
T120	Drug-Name 927 939	phototherapy
T121	Eq-Temporal-Period 947 955	previous
A18	Eq-Temporal-Period-Value T121 past
T122	Eq-Value 956 957	4
T123	Eq-Temporal-Unit 958 963	weeks
A19	Eq-Temporal-Unit-Value T123 week
T124	Eq-Temporal-Period 970 973	use
A20	Eq-Temporal-Period-Value T124 present
T125	Drug-Name 986 997	antibiotics
T126	Drug-Name 1001 1019	anti-mycotic drugs
T127	Eq-Value 1027 1028	4
T128	Eq-Temporal-Unit 1029 1034	weeks
A21	Eq-Temporal-Unit-Value T128 week
T129	Eq-Operator 1281 1287	within
A22	Eq-Operator-Value T129 LTEQ
T130	Eq-Value 1288 1291	two
T131	Eq-Temporal-Unit 1292 1297	weeks
A23	Eq-Temporal-Unit-Value T131 week
T132	Condition-Name 1334 1350	hypersensitivity